Team:Paris/Modeling/More RBS issue

From 2008.igem.org

(Difference between revisions)
Line 11: Line 11:
Thus, we can still evaluate the expression by keeping &#131;1 and &#131;2, but we must notice that the ''dissociation constant'' which we will estimate is not exactly the dissociation constant of the complexation ''FT''><''pFliL''. From now on, we understand that the calculated quantities of proteins by our global model are not the one in the "reality". Still, the purpose of our "Characterization Approach" is kept, by considering ''relative expression'' of the proteins...
Thus, we can still evaluate the expression by keeping &#131;1 and &#131;2, but we must notice that the ''dissociation constant'' which we will estimate is not exactly the dissociation constant of the complexation ''FT''><''pFliL''. From now on, we understand that the calculated quantities of proteins by our global model are not the one in the "reality". Still, the purpose of our "Characterization Approach" is kept, by considering ''relative expression'' of the proteins...
-
We can moreover notice that, by using these method in other circumstances, we can get ''predictive quantities'' and ''real constants'', by keeping always the same RBS (for example B0034) in all constructs !
+
We can moreover notice that, by using this method in other circumstances, we can get ''predictive quantities'' and ''real constants'', by keeping always the same RBS (for example B0034) in all constructs !

Revision as of 00:08, 29 October 2008

Let's see on our example why it is not a problem. Our wish is to characterize the strength of the promoter pFliL, in function of the transcriptions factors FlhDC and FliA. As it is explained in the characterisation protocol, it is done in two steps :

  • First, we study the activity of the promoters pTet and pBad, in function of the small molecules we introduce in the medium. It gives, with the standard RBS B0034, respectively the functions ƒ1 and ƒ2.
  • Then, we put the genes flhDC and fliA behind pTet and pBad, but with their natural RBS. In this order, we will get
[FlhDC] = {coefflhDC} * ƒ1 and [FliA] = {coeffliA} * ƒ2.

So,the pFliL added will have a given activity, measured with the RBS 0034 and GFP. We have shown in our modelisation that we expect it to have the following analytical expression :

F5analytic.jpg

that gives, with previous considerations and by dividing numerator and denominator by {coefgene}n :

F5RBS.jpg

Thus, we can still evaluate the expression by keeping ƒ1 and ƒ2, but we must notice that the dissociation constant which we will estimate is not exactly the dissociation constant of the complexation FT><pFliL. From now on, we understand that the calculated quantities of proteins by our global model are not the one in the "reality". Still, the purpose of our "Characterization Approach" is kept, by considering relative expression of the proteins...

We can moreover notice that, by using this method in other circumstances, we can get predictive quantities and real constants, by keeping always the same RBS (for example B0034) in all constructs !